Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Head Injuries, Penetrating | 9 | 2025 | 64 | 4.380 |
Why?
|
| Brain Injuries | 6 | 2023 | 169 | 2.230 |
Why?
|
| Chronic Pain | 8 | 2016 | 171 | 1.970 |
Why?
|
| Cerebral Hemorrhage | 8 | 2022 | 360 | 1.770 |
Why?
|
| Wounds, Gunshot | 3 | 2025 | 110 | 1.550 |
Why?
|
| Intracranial Hypertension | 2 | 2023 | 59 | 1.480 |
Why?
|
| Brain Ischemia | 5 | 2023 | 405 | 1.110 |
Why?
|
| Brain | 6 | 2025 | 2352 | 1.090 |
Why?
|
| Brain Injuries, Traumatic | 4 | 2022 | 105 | 1.070 |
Why?
|
| Decompressive Craniectomy | 3 | 2021 | 19 | 1.060 |
Why?
|
| Intracranial Pressure | 2 | 2023 | 90 | 1.020 |
Why?
|
| Stroke | 7 | 2024 | 1038 | 0.980 |
Why?
|
| Back Pain | 4 | 2016 | 65 | 0.870 |
Why?
|
| Neuroimaging | 1 | 2025 | 127 | 0.860 |
Why?
|
| Neurosurgical Procedures | 4 | 2023 | 312 | 0.820 |
Why?
|
| Thrombolytic Therapy | 5 | 2023 | 251 | 0.770 |
Why?
|
| Emergency Service, Hospital | 3 | 2021 | 559 | 0.760 |
Why?
|
| Intensive Care Units | 2 | 2023 | 429 | 0.750 |
Why?
|
| Brain Edema | 2 | 2021 | 61 | 0.730 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2021 | 52 | 0.720 |
Why?
|
| Injury Severity Score | 2 | 2021 | 150 | 0.720 |
Why?
|
| Neural Pathways | 4 | 2016 | 325 | 0.670 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2021 | 94 | 0.670 |
Why?
|
| Retrospective Studies | 14 | 2025 | 9703 | 0.670 |
Why?
|
| Blood Coagulation Disorders | 1 | 2021 | 66 | 0.660 |
Why?
|
| Electroencephalography | 1 | 2023 | 771 | 0.610 |
Why?
|
| Disease Models, Animal | 2 | 2023 | 2448 | 0.600 |
Why?
|
| Patient Readmission | 1 | 2022 | 393 | 0.560 |
Why?
|
| Nociceptors | 1 | 2016 | 30 | 0.530 |
Why?
|
| Adult | 17 | 2025 | 27532 | 0.480 |
Why?
|
| Neuronal Plasticity | 2 | 2016 | 195 | 0.480 |
Why?
|
| Humans | 41 | 2025 | 92337 | 0.470 |
Why?
|
| Hospitalization | 1 | 2021 | 927 | 0.470 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 31 | 0.430 |
Why?
|
| Middle Aged | 18 | 2025 | 27030 | 0.420 |
Why?
|
| Glasgow Coma Scale | 2 | 2023 | 78 | 0.410 |
Why?
|
| Male | 20 | 2025 | 43925 | 0.410 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2025 | 2680 | 0.400 |
Why?
|
| Intracranial Hemorrhages | 3 | 2023 | 130 | 0.360 |
Why?
|
| Female | 20 | 2025 | 47893 | 0.360 |
Why?
|
| Young Adult | 6 | 2025 | 6624 | 0.350 |
Why?
|
| Hospital Mortality | 2 | 2025 | 444 | 0.340 |
Why?
|
| Hematoma | 2 | 2021 | 107 | 0.330 |
Why?
|
| Predictive Value of Tests | 5 | 2021 | 1763 | 0.300 |
Why?
|
| Heart Rate | 2 | 2021 | 502 | 0.290 |
Why?
|
| Electrocardiography | 2 | 2021 | 507 | 0.280 |
Why?
|
| Inpatients | 2 | 2021 | 331 | 0.270 |
Why?
|
| Prospective Studies | 5 | 2022 | 4468 | 0.270 |
Why?
|
| Aged | 10 | 2025 | 19943 | 0.260 |
Why?
|
| Disease Progression | 4 | 2021 | 1503 | 0.260 |
Why?
|
| Treatment Outcome | 7 | 2024 | 8740 | 0.240 |
Why?
|
| Time Factors | 4 | 2024 | 5430 | 0.240 |
Why?
|
| Risk Factors | 5 | 2022 | 5704 | 0.220 |
Why?
|
| Adolescent | 4 | 2025 | 9504 | 0.220 |
Why?
|
| Neurophysiological Monitoring | 1 | 2023 | 17 | 0.220 |
Why?
|
| Automation | 1 | 2024 | 112 | 0.210 |
Why?
|
| Documentation | 1 | 2024 | 103 | 0.210 |
Why?
|
| Nucleus Accumbens | 2 | 2014 | 113 | 0.210 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2021 | 887 | 0.200 |
Why?
|
| Nerve Net | 3 | 2016 | 396 | 0.200 |
Why?
|
| Brain Death | 1 | 2023 | 86 | 0.200 |
Why?
|
| Prognosis | 5 | 2021 | 3872 | 0.200 |
Why?
|
| Length of Stay | 2 | 2023 | 798 | 0.200 |
Why?
|
| Comparative Effectiveness Research | 1 | 2023 | 55 | 0.200 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2023 | 63 | 0.200 |
Why?
|
| Death | 1 | 2023 | 92 | 0.190 |
Why?
|
| Swine | 1 | 2023 | 605 | 0.190 |
Why?
|
| Clinical Decision-Making | 2 | 2021 | 291 | 0.190 |
Why?
|
| Cerebrovascular Circulation | 1 | 2023 | 230 | 0.190 |
Why?
|
| Reward | 2 | 2014 | 201 | 0.190 |
Why?
|
| Family | 1 | 2023 | 324 | 0.190 |
Why?
|
| Thrombectomy | 4 | 2024 | 197 | 0.190 |
Why?
|
| Coma | 1 | 2021 | 49 | 0.190 |
Why?
|
| Monitoring, Physiologic | 1 | 2023 | 267 | 0.180 |
Why?
|
| Embolization, Therapeutic | 1 | 2024 | 260 | 0.180 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2016 | 3509 | 0.180 |
Why?
|
| Diabetes Insipidus, Neurogenic | 1 | 2020 | 4 | 0.180 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2021 | 12 | 0.180 |
Why?
|
| Vascular System Injuries | 1 | 2021 | 32 | 0.180 |
Why?
|
| Hypopituitarism | 1 | 2020 | 19 | 0.180 |
Why?
|
| Adrenal Insufficiency | 1 | 2020 | 23 | 0.180 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2021 | 171 | 0.180 |
Why?
|
| Hypocalcemia | 1 | 2020 | 43 | 0.170 |
Why?
|
| Hemostatics | 1 | 2021 | 59 | 0.170 |
Why?
|
| Life Support Care | 1 | 2021 | 51 | 0.170 |
Why?
|
| Patient Preference | 1 | 2021 | 120 | 0.170 |
Why?
|
| Amantadine | 1 | 2020 | 19 | 0.170 |
Why?
|
| Heart Conduction System | 1 | 2021 | 123 | 0.170 |
Why?
|
| Action Potentials | 2 | 2021 | 604 | 0.170 |
Why?
|
| Nootropic Agents | 1 | 2020 | 10 | 0.170 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2020 | 18 | 0.170 |
Why?
|
| Cerebral Veins | 1 | 2020 | 30 | 0.170 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2020 | 32 | 0.170 |
Why?
|
| Intracranial Thrombosis | 1 | 2020 | 30 | 0.170 |
Why?
|
| Withholding Treatment | 1 | 2021 | 115 | 0.170 |
Why?
|
| Patient Discharge Summaries | 1 | 2019 | 1 | 0.170 |
Why?
|
| Puerperal Disorders | 1 | 2020 | 37 | 0.160 |
Why?
|
| Neurologic Examination | 1 | 2020 | 124 | 0.160 |
Why?
|
| Wireless Technology | 1 | 2019 | 21 | 0.160 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2021 | 201 | 0.160 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2016 | 69 | 0.160 |
Why?
|
| Endovascular Procedures | 1 | 2023 | 309 | 0.160 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2021 | 159 | 0.160 |
Why?
|
| Survivors | 1 | 2020 | 199 | 0.160 |
Why?
|
| Hospitals, University | 1 | 2019 | 197 | 0.160 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2020 | 174 | 0.160 |
Why?
|
| Risk Assessment | 3 | 2021 | 2369 | 0.150 |
Why?
|
| Monitoring, Intraoperative | 1 | 2019 | 110 | 0.150 |
Why?
|
| Machine Learning | 1 | 2021 | 298 | 0.150 |
Why?
|
| Secondary Prevention | 1 | 2019 | 172 | 0.150 |
Why?
|
| Fibrinolytic Agents | 1 | 2020 | 233 | 0.150 |
Why?
|
| Ischemic Attack, Transient | 1 | 2020 | 186 | 0.150 |
Why?
|
| Decision Support Techniques | 1 | 2020 | 175 | 0.150 |
Why?
|
| Operating Rooms | 1 | 2019 | 134 | 0.150 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2021 | 471 | 0.150 |
Why?
|
| Hypothyroidism | 1 | 2020 | 264 | 0.150 |
Why?
|
| Cognition Disorders | 1 | 2020 | 240 | 0.150 |
Why?
|
| Continuity of Patient Care | 1 | 2019 | 176 | 0.140 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 358 | 0.140 |
Why?
|
| Tissue and Organ Procurement | 1 | 2022 | 380 | 0.140 |
Why?
|
| Prefrontal Cortex | 2 | 2016 | 141 | 0.140 |
Why?
|
| Seizures | 1 | 2020 | 312 | 0.140 |
Why?
|
| Databases, Factual | 1 | 2021 | 955 | 0.130 |
Why?
|
| Anticoagulants | 1 | 2020 | 443 | 0.130 |
Why?
|
| Patient Discharge | 1 | 2019 | 339 | 0.130 |
Why?
|
| Placebos | 1 | 2016 | 211 | 0.130 |
Why?
|
| Aged, 80 and over | 3 | 2023 | 6916 | 0.130 |
Why?
|
| Longitudinal Studies | 3 | 2016 | 1119 | 0.130 |
Why?
|
| Osteoarthritis, Knee | 1 | 2016 | 65 | 0.130 |
Why?
|
| Connectome | 1 | 2016 | 81 | 0.120 |
Why?
|
| Analgesics | 1 | 2016 | 122 | 0.120 |
Why?
|
| Amygdala | 1 | 2016 | 87 | 0.120 |
Why?
|
| White Matter | 1 | 2016 | 86 | 0.120 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 619 | 0.110 |
Why?
|
| Biomarkers | 1 | 2021 | 1850 | 0.110 |
Why?
|
| Cohort Studies | 1 | 2021 | 2978 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 1235 | 0.110 |
Why?
|
| Brain Mapping | 2 | 2014 | 580 | 0.110 |
Why?
|
| Risk-Taking | 1 | 2014 | 158 | 0.110 |
Why?
|
| Hippocampus | 1 | 2016 | 435 | 0.100 |
Why?
|
| Cells, Cultured | 1 | 2016 | 2902 | 0.090 |
Why?
|
| Pain | 1 | 2013 | 406 | 0.090 |
Why?
|
| Animals | 2 | 2023 | 28003 | 0.090 |
Why?
|
| Smoking | 1 | 2014 | 640 | 0.090 |
Why?
|
| Rats | 1 | 2016 | 4067 | 0.080 |
Why?
|
| Prevalence | 2 | 2021 | 1294 | 0.070 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 1774 | 0.060 |
Why?
|
| Diagnosis | 1 | 2024 | 18 | 0.060 |
Why?
|
| Radial Artery | 1 | 2024 | 36 | 0.050 |
Why?
|
| Catheters | 1 | 2024 | 85 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 2794 | 0.050 |
Why?
|
| Decision Making | 2 | 2021 | 680 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 1079 | 0.050 |
Why?
|
| Resuscitation | 1 | 2022 | 111 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2023 | 490 | 0.040 |
Why?
|
| Head Injuries, Closed | 1 | 2020 | 12 | 0.040 |
Why?
|
| Electrolytes | 1 | 2020 | 53 | 0.040 |
Why?
|
| Pituitary-Adrenal System | 1 | 2020 | 64 | 0.040 |
Why?
|
| Patient Admission | 1 | 2021 | 116 | 0.040 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2020 | 81 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2024 | 364 | 0.040 |
Why?
|
| Triage | 1 | 2021 | 125 | 0.040 |
Why?
|
| Ventriculostomy | 1 | 2020 | 30 | 0.040 |
Why?
|
| Egypt | 1 | 2019 | 14 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2014 | 1902 | 0.040 |
Why?
|
| Spinal Injuries | 1 | 2020 | 27 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2021 | 325 | 0.040 |
Why?
|
| Mortality | 1 | 2020 | 150 | 0.040 |
Why?
|
| Hematologic Diseases | 1 | 2020 | 78 | 0.040 |
Why?
|
| Materials Testing | 1 | 2019 | 94 | 0.040 |
Why?
|
| Craniocerebral Trauma | 1 | 2020 | 57 | 0.040 |
Why?
|
| Patient Participation | 1 | 2021 | 228 | 0.040 |
Why?
|
| Sodium | 1 | 2020 | 335 | 0.040 |
Why?
|
| Thyroid Gland | 1 | 2020 | 280 | 0.040 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2020 | 82 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 120 | 0.040 |
Why?
|
| Physical Therapy Modalities | 1 | 2019 | 87 | 0.040 |
Why?
|
| Vascular Diseases | 1 | 2020 | 120 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2019 | 159 | 0.040 |
Why?
|
| Acute Disease | 1 | 2020 | 856 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2020 | 156 | 0.040 |
Why?
|
| Equipment Design | 1 | 2019 | 418 | 0.040 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2020 | 283 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2020 | 317 | 0.040 |
Why?
|
| Quality Indicators, Health Care | 1 | 2019 | 152 | 0.040 |
Why?
|
| Intracranial Aneurysm | 1 | 2020 | 197 | 0.040 |
Why?
|
| Guideline Adherence | 1 | 2019 | 239 | 0.040 |
Why?
|
| Health Status | 1 | 2019 | 376 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2019 | 900 | 0.030 |
Why?
|
| Functional Neuroimaging | 1 | 2016 | 31 | 0.030 |
Why?
|
| Physician-Patient Relations | 1 | 2021 | 630 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2019 | 473 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 1661 | 0.030 |
Why?
|
| Rest | 1 | 2014 | 51 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2014 | 90 | 0.030 |
Why?
|
| Cues | 1 | 2013 | 177 | 0.020 |
Why?
|
| Smoking Cessation | 1 | 2014 | 265 | 0.020 |
Why?
|
| Impulsive Behavior | 1 | 2014 | 290 | 0.020 |
Why?
|
| Child | 1 | 2022 | 7334 | 0.020 |
Why?
|
| Logistic Models | 1 | 2014 | 1239 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2013 | 693 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 3775 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2014 | 2729 | 0.020 |
Why?
|